Phenomix Sciences

Phenomix Sciences

Verified
Phenomix Sciences an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$22—33m (Dealroom.co estimates May 2024.)
Saint Paul Minnesota (HQ)
Deals in current and previous year:
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
investor

$0.0

round
N/A

$0.0

round
investor investor investor

$0.0

round
*

$2.3m

Grant
Total Funding000k

Recent News about Phenomix Sciences

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Phenomix Sciences

Edit